Quarterly report · Q3
9265.TEDINET S100T8KZ
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥45.4bn | 2023-06-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥58.2bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥41.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥830m | 2023-06-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥895m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥871m | 2023-06-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥936m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥721m | 2023-06-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥333m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥442m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥219m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥438m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | −¥3m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥25.6bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥22.5bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.2bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥16.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.4bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥7.7bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.5bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.8bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥173.23 | 2023-06-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.83 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.83 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.46 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.44 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 32.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-06-01 → 2024-02-29 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2024-02-29 | −¥844m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥209m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥209m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥2m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥45.1bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥45.1bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥1.7bn |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥51m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥51m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥1m |
| —segment total | revenue | 2023-06-01 → 2024-02-29 | ¥45.4bn |
| —segment total | revenue external | 2023-06-01 → 2024-02-29 | ¥45.4bn |
| —segment total | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥0 |
| —segment total | segment profit | 2023-06-01 → 2024-02-29 | ¥1.7bn |
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-02-28 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-02-28 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥690m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥211m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥211m |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥0 |
| jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥10m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥41.5bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥41.5bn |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥11m |
| jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥1.6bn |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥50m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥50m |
| jpcrp040300-q3r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2023-02-28 | ¥41.7bn |
| —segment total | revenue external | 2022-06-01 → 2023-02-28 | ¥41.7bn |
| —segment total | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2023-02-28 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 366
| Item | Context | Value | Unit |
|---|---|---|---|
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 5825000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 4548000000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 10492000000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 11543000000 | JPY |
| Merchandise | Prior1YearInstant | 2891000000 | JPY |
| Merchandise | CurrentQuarterInstant | 3021000000 | JPY |
| Other ca | Prior1YearInstant | 323000000 | JPY |
| Other ca | CurrentQuarterInstant | 1194000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -15000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -18000000 | JPY |
| Current assets | Prior1YearInstant | 19516000000 | JPY |
| Current assets | CurrentQuarterInstant | 20288000000 | JPY |
| Buildings and structures | Prior1YearInstant | 3646000000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 3498000000 | JPY |
| Accumulated depreciation buildings and structures | Prior1YearInstant | -2095000000 | JPY |
| Accumulated depreciation buildings and structures | CurrentQuarterInstant | -2182000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 1551000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 1315000000 | JPY |
| Land | Prior1YearInstant | 1649000000 | JPY |
| Land | CurrentQuarterInstant | 1687000000 | JPY |
| Other ppe | Prior1YearInstant | 817000000 | JPY |
| Other ppe | CurrentQuarterInstant | 782000000 | JPY |
| Accumulated depreciation other ppe | Prior1YearInstant | -691000000 | JPY |
| Accumulated depreciation other ppe | CurrentQuarterInstant | -661000000 | JPY |
| Other net ppe | Prior1YearInstant | 125000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 120000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 3326000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 3123000000 | JPY |
| Goodwill | Prior1YearInstant | 56000000 | JPY |
| Goodwill | CurrentQuarterInstant | 303000000 | JPY |
| Other ia | Prior1YearInstant | 55000000 | JPY |
| Other ia | CurrentQuarterInstant | 45000000 | JPY |
| Intangible assets | Prior1YearInstant | 111000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 348000000 | JPY |
| Investment securities | Prior1YearInstant | 1015000000 | JPY |
| Investment securities | CurrentQuarterInstant | 1273000000 | JPY |
| Stocks of subsidiaries and affiliates | Prior1YearInstant | 22000000 | JPY |
| Stocks of subsidiaries and affiliates | CurrentQuarterInstant | 17000000 | JPY |
| Claims provable in bankruptcy claims provable in rehabilitation and other | Prior1YearInstant | 612000000 | JPY |
| Claims provable in bankruptcy claims provable in rehabilitation and other | CurrentQuarterInstant | 557000000 | JPY |
| Other ioa | Prior1YearInstant | 576000000 | JPY |
| Other ioa | CurrentQuarterInstant | 581000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -612000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -557000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |